Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Lucira Health stock | $4.94
Learn how to easily invest in Lucira Health stock.
Lucira Health, an Emeryville, California-based company that develops infectious disease test kits, completed an upsized IPO for $153 million, selling 9 million shares at $17 each.
Shares of LHDX opened at $22.10 and climbed more than 31% in early trading.
How to buy shares in Lucira Health
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – LHDX – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Lucira Health stock price (NASDAQ: LHDX)Use our graph to track the performance of LHDX stocks over time.
Lucira Health shares at a glance
|Latest market close||$4.94|
|52-week range||$4.23 - $37.99|
|50-day moving average||$6.31|
|200-day moving average||$10.75|
|Wall St. target price||$8.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||N/A|
Buy Lucira Health shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Lucira Health stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Lucira Health price performance over time
|1 week (2021-07-23)||N/A|
|1 month (2021-07-02)||-26.71%|
|3 months (2021-05-03)||-17.39%|
|6 months (2021-01-30)||N/A|
|1 year (2020-07-30)||N/A|
|2 years (2019-07-30)||N/A|
|3 years (2018-07-30)||N/A|
|5 years (2016-07-30)||N/A|
Lucira Health financials
|Revenue TTM||$4.8 million|
|Gross profit TTM||$-1,672,000|
|Return on assets TTM||-39.78%|
|Return on equity TTM||-116.59%|
|Market capitalisation||$363.7 million|
TTM: trailing 12 months
Shorting Lucira Health shares
There are currently 1.7 million Lucira Health shares held short by investors – that's known as Lucira Health's "short interest". This figure is 30.1% up from 1.3 million last month.
There are a few different ways that this level of interest in shorting Lucira Health shares can be evaluated.
Lucira Health's "short interest ratio" (SIR)
Lucira Health's "short interest ratio" (SIR) is the quantity of Lucira Health shares currently shorted divided by the average quantity of Lucira Health shares traded daily (recently around 1.2 million). Lucira Health's SIR currently stands at 1.47. In other words for every 100,000 Lucira Health shares traded daily on the market, roughly 1470 shares are currently held short.
To gain some more context, you can compare Lucira Health's short interest ratio against those of similar companies.
However Lucira Health's short interest can also be evaluated against the total number of Lucira Health shares, or, against the total number of tradable Lucira Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Lucira Health's short interest could be expressed as 0.04% of the outstanding shares (for every 100,000 Lucira Health shares in existence, roughly 40 shares are currently held short) or 0.0593% of the tradable shares (for every 100,000 tradable Lucira Health shares, roughly 59 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Lucira Health.
Find out more about how you can short Lucira Health stock.
Lucira Health share dividends
We're not expecting Lucira Health to pay a dividend over the next 12 months.
You may also wish to consider:
- Agilent Technologies (A.US) (0.49% forward annual dividend yield)
Lucira Health overview
Lucira Health, Inc. , a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co. , Ltd. ; technical services agreement with Jabil, Inc.
Stocks similar to Lucira Health
Lucira Health in the news
Will Lucira Health (NASDAQ:LHDX) Spend Its Cash Wisely?
Wall Street Breakfast: The Week Ahead (Podcast)
Wall Street Breakfast: The Week Ahead
Frequently asked questionsWhat percentage of Lucira Health is owned by insiders or institutions?
Currently 3.59% of Lucira Health shares are held by insiders and 50.102% by institutions. How many people work for Lucira Health?
Latest data suggests 71 work at Lucira Health. When does the fiscal year end for Lucira Health?
Lucira Health's fiscal year ends in December. Where is Lucira Health based?
Lucira Health's address is: 1412 62nd Street, EmeryVille, CA, United States, 94608
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert